Study site

Miami, Florida 33183

1 studies enrolling now · 12 studies all time

What they study most

Adolescent Schizophrenia, Alpha1-proteinase Inhibitor Deficiency, Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features, Emphysema, Factor XIII Deficiency, Healthy, Healthy Adult Male and Female Volunteers, Hemophilia A, Schizophrenia, Stable Atherothrombotic Disease, Type 2 Diabetes

Studies at this site

• Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol — Recruiting now
• Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes — Completed
• A Phase 1 First in Human Study to Assess Safety and Tolerability of AL101 — Completed
• An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A — Completed
• Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features. — Stopped early
• A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects — Completed
• A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes — Completed
• Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus — Completed
• Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia — Completed
• Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency — Completed
• A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients — Completed
• An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency — Completed